Clinical Trials Directory

Trials / Completed

CompletedNCT01180920

The Importance of Periostin in Periodontal Health and Disease

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to determine the clinical importance of Periostin in oral health and disease. The long-term goal will be to develop practical applications for the diagnosis, treatment, prevention and cure of human periodontal diseases.

Detailed description

It is hypothesized that Periostin levels are decreased during periodontal diseases, thereby, elevating the hosts' susceptibility to periodontal breakdown. The specific aims are the following; To determine if Periostin is a biomarker of periodontal disease, and To evaluate Periostin in periodontal tissue healing and homeostasis by harvesting healthy or diseased tissue from 22 patients requiring periodontal surgery.

Conditions

Timeline

Start date
2011-06-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2010-08-12
Last updated
2014-12-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01180920. Inclusion in this directory is not an endorsement.

The Importance of Periostin in Periodontal Health and Disease (NCT01180920) · Clinical Trials Directory